forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Receptor Agonist Market Report, 2033 Chart: 1 in 8 Americans

GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer

Specs Free trial length: 14 days Special features: Psychology-based daily lessons, color-coded food logging system, and coaching-supported app Calorie tracking: Yes Coaching: Yes Best Weight Loss Program for Workouts: Simple Simple Our thoughts: Fasting, food logging, and bitesize workouts with clear prompts Who its for: Folks who want an allinone fasting and activity app What makes it different: The app has a gamified scoring system that rewards consistency Pros Integrated fasting, food, hydration, and movement tracking Quick, appbased workout prompts and video snippets that fit into a busy day AI coach and success score that reward consistency Cons Free version is limited

Setmelanotide Injection

The FDAs endorsement of these drugs for weight management, irrespective of a diabetes diagnosis, underscores their potential

SGLT2 inhibition reduces glucose reabsorption at the level of the proximal renal tubule, promotes urinary glucose excretion independent of insulin action, and causes a negative caloric balance ( Figure 1 )

Other combinations, such as GLP-1/gastrin co-agonists and GLP-1/GIP co-agonists, are also under development